Rhinosinusitis Clinical Trial
Official title:
Prospective Study Investigating the Role of Occupational Exposure on Sinus Surgery Outcome
Verified date | May 2011 |
Source | Universitaire Ziekenhuizen Leuven |
Contact | n/a |
Is FDA regulated | No |
Health authority | Belgium: UZLeuven |
Study type | Observational |
The pathophysiology of chronic rhinosinusitis (CRS) is complex and involves several immune,
infectious and anatomic factors. When medical therapy fails, functional endoscopic sinus
surgery (FESS) is the therapy of choice. From literature it is known that 10% of patients
that undergo FESS, need revision surgery within the 3 years following initial surgery.
Causes of failure are multiple and not fully understood.
As is the case in patients suffering from occupational rhinitis (OR), a subgroup of patients
with severe and/or therapy resistent rhinosinusitis may suffer from mucosal pathology
induced by occupational factors as well. No data are currently available on how these
factors may contribute to the disease manifestation, whereas negligence of these factors as
potential causes of disease may lead to the chronicity of rhinosinusitis, aggravate the
mucosal condition and even give rise to the induction of bronchial symptoms. There exists no
documentation on the role of the occupational agents on chronic sinus disease.
This prospective study aims at providing data about the exposure levels of patients that
undergo sinus surgery and correlate them with both subjective and objective postoperative
parameters. This will be done by providing a questionnaire that was developed at our
department to all patients that are planned for sinus surgery at the participating centers.
This questionnaire asks for medical history, current sinonasal symptoms, professional
history and recreational occupation. An extensive list of occupational agents is given and
patients are asked to indicate those that they encounter at work or during recreational
activities. This will be followed by an extensive clinical investigation including nasal
endoscopy. These investigations (questionnaire and clinical examination) will be repeated at
3 months and 12 months after surgery.
Status | Not yet recruiting |
Enrollment | 200 |
Est. completion date | September 2013 |
Est. primary completion date | March 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: 1. Patients scheduled for sinus surgery because of recurrent acute sinusitis or chronic sinusitis with or without nasal polyps. 2. Age > 18 and < 65 years 3. Signed informed consent 4. Willingness and capability to fill in questionnaire. Exclusion Criteria: 1. Patient with diagnosed cystic fibrosis or primary ciliary dysfunction syndrome 2. Patients that undergo FESS for antrochoanal polyp 3. Patient that undergo FESS for a malignant process 4. Patient that are diagnosed with sarcoidosis or any type of vasculitis |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Universitaire Ziekenhuizen Leuven | AMC Amsterdam, AZ Sint-Lucas, Hopital Sint-Luc Bruxelles, University Hospital, Ghent |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02636790 -
Early Versus Late Surgical Wait Times
|
Early Phase 1 | |
Completed |
NCT02712502 -
Levofloxacin in Bacterial Rhinosinussitis
|
N/A | |
Completed |
NCT00986830 -
Healthcare Utilization and Outcomes of FinESS Treatment in the Office
|
N/A | |
Completed |
NCT00534079 -
Nasal Inhalation of Pulmozyme in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
|
Phase 3 | |
Completed |
NCT05442606 -
Physiotherapy Protocol in Treating Chronic Rhinosinusitis
|
N/A | |
Completed |
NCT01955980 -
Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis
|
Phase 1/Phase 2 | |
Completed |
NCT04123405 -
Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis
|
Phase 3 | |
Completed |
NCT00797004 -
Olfactory Dysfunction of Rhinosinusitis
|
N/A | |
Recruiting |
NCT05494346 -
Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction
|
N/A | |
Not yet recruiting |
NCT05836935 -
Role of Imaging in Complications of Sinusitis
|
N/A | |
Withdrawn |
NCT02097576 -
Manuka Honey Nasal Rinse Study
|
N/A | |
Completed |
NCT01132781 -
Theophylline in Rhinitis
|
Phase 2 | |
Recruiting |
NCT00948519 -
Laser Assisted Treatment of Chronic Sinusitis With and Without Light Activated Agents
|
N/A | |
Completed |
NCT00554190 -
Study to Evaluate Safety and Effectiveness of AdvaCoat Sinus Gel
|
Phase 4 | |
Recruiting |
NCT03729258 -
Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis.
|
Phase 3 | |
Withdrawn |
NCT03729310 -
Comparison of Two Steroid Nasal Implants Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis
|
Early Phase 1 | |
Recruiting |
NCT01296919 -
The Clinical Significance of the Uncinate Process Histopathology in Chronic Rhinosinusitis
|
N/A | |
Completed |
NCT01086839 -
Sino-nasal Inhalation of Sodium Chloride 6,0% in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
|
N/A | |
Completed |
NCT00849953 -
FinESS Registry Study
|
N/A | |
Withdrawn |
NCT00669799 -
Topical Antibiotic Use In Chronic Rhinosinusitis A Double-Blinded, Randomized, Placebo Controlled Study
|
N/A |